Статья
Конгресс Американского колледжа кардиологов: результаты клинических исследований
Представлен отчет о 15 важнейших клинических исследованиях, представлявшихся на научных сессиях Американского колледжа кардиологов, проходивших в Орландо (США) 10-12 марта 2018 года.
1. Steg P., Szarek M., Bhatt D. et al. Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the ODYSSEY Outcomes Trial. ACC Scientific Sessions, March 10, 2018, Orlando, Florida. https://www.medscape.com/cardiology
2. Notarangelo F. M., Maglietta G., Bevilacqua P. et al. Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndromes: PHARMCLO trial. J Am Coll Cardiol. 2018 Feb 24.
3. Berwanger O., Nicolau J. C., Carvalho A. C. et al. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2018 Mar 11.
4. Hahn J. Y., Song Y. B., Oh J. H. et al. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMARTDATE): a randomised, open-label, non-inferiority trial. Lancet. 2018 Mar 9.
5. Berwanger O., Santucci E. V., de Barros E. Silva P. G. M. et al. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial. JAMA. 2018 Mar 11.
6. Olgin J. E., Pletcher M., Vittinghoff E. et al. Efficacy of a Wearable Cardioverter-Defibrillator after Myocardial Infarction: Results of the Vest Prevention of Early Sudden Death Trial (VEST). ACC Scientific Sessions, March 10, 2018, Orlando, Florida. https:// www.medscape.com/cardiology
7. Steinhubl S. R., Waalen J., Edwards A. et al. A Digital End-to-End, Nationwide, Pragmatic Trial of Screening for Undiagnosed Atrial Fibrillation Within a Health Insurance System Using a Self-Applied ECG Patch: Primary Results of the mHealth Screening to Prevent Strokes (mSToPS) Trial. ACC Scientific Sessions, March 10, 2018, Orlando, Florida. https://www.medscape.com/cardiology
8. Kumbhan D.J. Management of Myocardial Injury After Noncardiac Surgery - MANAGE. ACC Scientific Sessions, March 11, 2018, Orlando, Florida. https://www.medscape.com/cardiology
9. Smilowitz N. R., Beckman J. A., Sherman S. E., Berger J. S. Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery. Circulation. 2018 Mar 10.
10. Mehra M. R., Goldstein D.J., Uriel N. et al. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Mar 11.
11. Pandey A., Patel K. V., Liang L. et al. Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2018 Mar 12.
12. Connolly S. Interim Report on the ANNEXA-4 Study: Andexanet for Reversal of Anticoagulation in Factor Xa - Associated Acute Major Bleeding. ACC Scientific Sessions, March 10, 2018, Orlando, Florida. https://www.medscape.com/cardiology
13. Kim S. C., Neogi T., Kang E. H. et al. Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout. J Am Coll Cardiol. 2018;71 (9):994-1004.
14. Avila M. S., Ayub-Ferreira S. M., de Barros Wanderley Junior M. R. et al. Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity. J Am Coll Cardiol. 2018 Mar 3.
15. Victor R. G., Lynch K,. Li N. et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018 Mar 12.